Ambit Biosciences Corporation (AMBI) Thursday said it priced the initial public offering of 8,125,000 shares at $8.00 per share. The stock is scheduled to begin trading on The NASDAQ Global Market on May 16 under the symbol 'AMBI.'
The firm said underwriters have been granted a 30-day option to purchase up to an additional 1,218,750 shares at the initial public offering price to cover over-allotments, if any.
The joint book-running managers for the offering are Citigroup and Leerink Swann. In addition, BMO Capital Markets is acting as lead manager and Robert W. Baird & Co. Inc. is acting as co-manager.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.